| Quote | Spy CHTP NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Chelsea Therapeutics Reports Q4 Loss of $0.18
CHTP Linked by StreetInsider - March 10, 04:27PM from (www.streetinsider.com) more ...
Chelsea Therapeutics Reports Better-Than-Expected Q3 Loss of $0.22
CHTP Linked by StreetInsider - November 02, 04:41PM from (www.streetinsider.com) more ...
Just about everything weighs on markets today (F, PAG, ETP, ASTI, CHTP)
F ETP PAG CHTP ASTI Linked by BloggingStocks - October 01, 04:43PM from (www.pheedcontent.com) The markets opened lower this morning and have continued to slide all day, mostly due to poor reports on manufacturing and more ...
Closing bell: home sales don't help (AONE, BAC, WFC, GE, CHTP, JPM)
JPM GE BAC WFC AONE CHTP FAZ Linked by BloggingStocks - September 24, 04:43PM from (www.pheedcontent.com) The market seems to want to go up each day as it has relentlessly almost every trading session since April. But yesterday, more ...
Chelsea Therapeutics International "buy," target price reduced
CHTP Linked by newratings - March 05, 12:43PM from (www.newratings.com) NEW YORK, March 5 (newratings.com) - Analysts at Roth Capital reiterate their "buy" rating on Chelsea Therapeutics more ...
Chelsea Therapeutics Reports Q4 Results
CHTP Linked by StreetInsider - March 04, 07:45AM from (www.streetinsider.com) more ...
Chelsea Therapeutics International "buy," target price raised
CHTP Linked by newratings - August 07, 10:13AM from (www.newratings.com) NEW YORK, August 7 (newratings.com) - Analysts at Roth Capital reiterate their "buy" rating on Chelsea Therapeutics more ...
Biotech Business Daily (CHTP, CRXL, LLY, IOMI, MEDX, TRCA)
LLY MEDX IOMI CRXL TRCA CHTP Linked by 24/7 Wall St. - May 13, 01:10PM from (www.247wallst.com) Chelsea Therapeutics International, Ltd. (NASDAQ: CHTP) falling today after first quarter earnings showed wider losses than more ...
Analyst initiations 7-25-07
CHRS GOK ERTS TTWO KG CHINA CHTP BIOF Linked by MarketMaster106 - July 25, 11:56AM from (www.bloggingstocks.com) MOST NOTEWORTHY: VeraSun Energy, BioFuel Energy, Electronic Arts and Take-Two Interactive Software were today's noteworthy more ...
Chelsea Therapeutics Initiates CH-1504 Bioequivalence Study
CHTP Linked by insiderhound - June 27, 05:10PM from (www.irconnect.com) Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) has begun dosing volunteers in its bioequivalence study of CH-1504, more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2010 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.
|
|